Clinical Trial: Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission: A Prospective, Multicenter Cohort Study

U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577531) titled 'Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission: A Prospective, Multicenter Cohort Study' on May 04.

Brief Summary: To evaluate, through a prospective multicenter observational study, autologous or allogeneic hematopoietic stem cell transplantation as consolidation therapy in subjects with T-ALL/LBL who have achieved first complete remission (CR). Assess relapse-free survival (RFS), overall survival (OS), cumulative incidence of relapse (CIR), and non-relapse mortality (NRM) among different treatment regimens

Study Start Date: May 05

Study Type: ...